Additionally, they found that IDH mutations correlated with advanced patient age, higher tumor grade, larger tumor diameter, and specific tumor sites, each of which are variables that have also independently been shown to correlate with patient survival [11]. This evidence concerns the gene IDH2 and neoplasm.